Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
cancer
5
×
life sciences
national blog main
san francisco blog main
biotech
cancer drugs
clinical trials
national top stories
san francisco top stories
blueprint medicines
eli lilly
europe blog main
ipo
non-small cell lung cancer
revolution medicines
roche
san francisco
sanofi
the column group
third rock ventures
warp drive bio
amgen
avapritinib
black diamond therapeutics
bladder cancer
boston
capmatinib
cobimetinib
colorectal cancer
community oncology alliance
cvs health
deals
deciphera pharmaceuticals
dna sequencing
drew pardoll
electronic health records
endometral cancer
europe top stories
What
cancer
5
×
medicines
5
×
drug
ipo
research
new
proteins
revolution
targeted
targets
address
aim
approval
approves
biotech
black
blueprint
boost
cancer’s
carries
certain
change
clinic
community
companies
designed
despite
diagnostics
diamond
disease
docs
eluded
family
fda
flatiron
frontiers
genetic
hardest
helped
hit
Language
unset
Current search:
medicines
×
cancer
×
cancer
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
With OneOncology, Flatiron and Cancer Docs Aim to Boost Community Care